Unnecessary downtime can be expensive for pharmaceutical manufacturing operations; unplanned stoppages can delay the delivery of much needed product, potentially causing damage to a company's reputation.

Advances in the application of artificial intelligence (AI) are starting to have a significant impact on automation technologies used across industry—most notably with machine vision and analytics. And some of the more impactful applications of AI are happening in the pharmaceutical industries. Learn more in this article from Automation World.

In this article from European Pharmaceutical Review, David Leitham, Senior Vice President and General Manager at AspenTech®, explains how implementing PAT pushes the industry towards Pharma 4.0. Download this article to learn more.

2015年《巴黎协定》和其他国际气候变化协定有助于提高全球对各国需要采取紧急行动应对气候变化的认识。随着企业继续关注可持续性，围绕数字化作为关键推动因素的作用，一个共同的主题正在形成。事实上，ARC咨询集团最近的一项调查显示，75%的受访者认为数字化转型对于实现可持续发展目标非常重要。

The 2015 Paris Agreement and other international climate change accords have helped raise global awareness of the need for countries to take urgent action to combat climate change. As companies continue to focus on sustainability, a common theme is taking shape around the role of digitalization as a key enabler. In fact, a recent ARC Advisory Group survey revealed that 75% of respondents rated digital transformation as highly important for achieving sustainability goals.

In this article for European Pharmaceutical Manufacturer, Richard Porter, AspenTech Pharmaceutical Director looks at how automated technologies are helping pharma companies transform their manufacturing processes.

As all companies have been challenged by the current economic and health crisis, the successful recovery requires a new view toward future development and growth with metrics that consider broad and more long-term goals. Featured in Hydrocarbon Processing, AspenTech’s Paige Morse shares considerations for building future resiliency that center around digitalization.